203 results
Page 2 of 11
20-F/A
5rl66
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
ofzpcppihj9p90ta6ba
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.1
e2zb90kcb58e48g7
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
d4po3g 97uzcffk
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
c38y6h trg84sq2lq
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
lxmrzs96n326ro
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
4gzy2bu4 89hbit
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
slzy xswg44
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
k9fuq
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
7d690rg
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
kk22pjyj0ns
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
9d92o9kc
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.4
b34xpa63 x3nrpy
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
wmf3mqtvl8qqemaw 86
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
74l07ybka 5t03
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
uwpk95h2tucp8mqhet
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
5vq7 xie1w
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
12l83cqf7mn0z
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
g978muu6oqjs tb1
21 Dec 21
51-102F3 Material Change Report
5:28pm